Severe Strongyloidiasis in Solid Organ Transplant Recipients: Should We Preventively Treat the Recipient, the Donor, or Both?

Am J Trop Med Hyg

Département d'Urologie, Néphrologie et Transplantation, Assistance Publique-Hôpitaux de Paris, Hôpital Pitié-Salpêtrière Charles Foix, Paris, France.

Published: April 2018

Strongyloidiasis is caused by a soil-transmitted helminth that is endemic in tropical and subtropical countries. The parasite can complete its life cycle without leaving the host, allowing autoinfection and persistence. The risk of infection in travelers is low, but the disease may become lethal following immunosuppression. In case of solid organ transplantation, the risk of donor transmission has been suspected for several years. However, the management of live donors in this context has only recently been considered, and no guidelines exist for the management of deceased donors. To highlight the complexity of diagnosing, treating, and preventing strongyloidiasis donor transmission, we describe a case of possible transmission of severe strongyloidiasis to a kidney transplant recipient with limited travel history. Taking into account the difficulty of diagnosing chronic strongyloidiasis infection and the increase in travel and immunosuppressive treatments, we recommend pragmatic management guidelines to limit the risks of infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928809PMC
http://dx.doi.org/10.4269/ajtmh.17-0234DOI Listing

Publication Analysis

Top Keywords

severe strongyloidiasis
8
solid organ
8
donor transmission
8
strongyloidiasis solid
4
organ transplant
4
transplant recipients
4
recipients preventively
4
preventively treat
4
treat recipient
4
recipient donor
4

Similar Publications

is an intestinal nematode. It is widely distributed in the tropics and sub-tropics of the world. It can cause a wide array of illnesses ranging from asymptomatic autoinfection to a severe form of hyperinfection and disseminated strongyloidiasis.

View Article and Find Full Text PDF

Strongyloides hyperinfection and disseminated infections are usually associated with immunosuppression; these severe manifestations occur in a minority of cases. The use of immunosuppressants such as corticosteroids and Baricitinib for treating COVID-19 pneumonia can be responsible for patients' immunosuppression and cause Strongyloides hyperinfection syndrome. The chance increases when the patient belongs to countries or regions where chronic infection with Strongyloides is more prevalent.

View Article and Find Full Text PDF

Cytomegalovirus (CMV) infection is an opportunistic disease in immunocompromised patients that may appear without symptoms, with constitutional symptoms, or as a tissue-invasive disease. infection often manifests with non-specific symptoms; however, it can lead to severe malabsorption and extraintestinal dissemination by accelerated autoinfection. The coinfection of CMV and has rarely been reported, particularly with solely severe gastrointestinal bleeding.

View Article and Find Full Text PDF

Parasitic Infections in Pulmonary and ICU Patients: Presentation, Diagnosis, and Treatment.

Chest

November 2024

Infectious Diseases Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX. Electronic address:

Article Synopsis
  • Parasitic infections in the U.S. primarily affect immigrants and travelers, often leading to delayed diagnoses by physicians unfamiliar with these diseases.
  • Nearly 2,000 cases of imported malaria occur annually, with severe symptoms that can mimic bacterial sepsis, and treatment requires careful management to improve survival.
  • Strongyloidiasis, endemic in warm regions, can stay dormant for years and worsen if corticosteroids are used, while other infections like cystic echinococcosis and paragonimus present with specific respiratory symptoms and are found in various global regions, including parts of North America.
View Article and Find Full Text PDF
Article Synopsis
  • Strongyloidiasis is a neglected tropical disease that poses significant risks to immunosuppressed individuals, yet it hasn't been thoroughly researched in Sri Lanka.
  • This study involved immunocompromised patients, using various diagnostic methods, including fecal microscopy, molecular PCR, and serology to detect the parasite Strongyloides stercoralis.
  • Results showed low detection rates for strongyloidiasis; only one fecal sample tested positive through traditional cultures, while PCR and ELISA revealed 11.4% and 16.4% positivity, respectively, indicating a need for improved diagnostic methods.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!